Skip to main

Blocking CCL8-CCR8–mediated early allograft inflammation improves kidney transplant function

Blocking CCL8-CCR8–mediated early allograft inflammation improves kidney transplant function

COTS invites the authors to discuss the CCL8-CCR8 axis as a promising measure to reduce early kidney allograft inflammation.

  • 2:00 PM - 3:00 PM EDT
  • Virtual, as part of the AST Journal Club Series.

"Blocking CCL8-CCR8–mediated early allograft inflammation improves kidney transplant function"
(J Am Soc Nephrol. 2022 Oct;33(10):1876-1890. doi: 10.1681/ASN.2022020139. Epub 2022 Aug 16.)

In this article:
In kidney transplantation, early allograft inflammation impairs long-term allograft function. However, precise mediators of early kidney allograft inflammation are unclear, making it challenging to design therapeutic interventions. [The authors found that] targeting the CCL8-CCR8 axis is a promising measure to reduce early kidney allograft inflammation.

Speaker:
- Xunrong Luo, MD, PhD, FAST • Duke University, Durham, NC

Moderator:
- Andrew Wells, PhD • University of Pennsylvania, Philadelphia, PA

Hosted by AST's Community of Transplant Scientists (COTS). All AST Journal Clubs, and featured AST/AJT Journal Clubs, are free but registration is required to attend live.


Learn more about the AST Journal Club Series

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi